Inhaled Biologicals for the Treatment of Cystic Fibrosis

BACKGROUND: Cystic Fibrosis (CF), one of the most frequent genetic diseases, is characterized by the production of viscous mucus in several organs. In the lungs, mucus clogs the airways and traps bacteria, leading to recurrent/resistant infections and lung damage. For cystic fibrosis patients, respi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sala, Valentina, Murabito, Alessandra, Ghigo, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751348/
https://www.ncbi.nlm.nih.gov/pubmed/30318010
http://dx.doi.org/10.2174/1872213X12666181012101444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751348/
https://www.ncbi.nlm.nih.gov/pubmed/30318010
http://dx.doi.org/10.2174/1872213X12666181012101444

Ejemplares similares